Liver regeneration: Mechanisms and clinical relevance

Blumgart's Surgery of the Liver, Biliary Tract and Pancreas

Volumn , Issue , 2012, Pages 87-101

  Jonge, Jeroen De ^a   Olthoff, Kim Marie ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884800469     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1454-8.00005-9     Document Type: Chapter

References (302)

1. Abdalla EK, Hicks ME, Vauthey JN Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001, 88(2):165-175.
2. Abdalla EK, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002, 137(6):675-680. discussion 680-671.
3. Abdel Aziz MT, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007, 40(12):893-899.
4. Abt PL, et al. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 2004, 4(8):1302-1307.
5. Aldeguer X, et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002, 35(1):40-48.
6. Alison MR, et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000, 406(6793):257.
7. Alison MR, Islam S, Lim S Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 2009, 217(2):282-298.
8. Ambros V The functions of animal microRNAs. Nature 2004, 431(7006):350-355.
9. Anderson SP, et al. Delayed liver regeneration in peroxisome proliferators-activated receptor-alpha-null mice. Hepatology 2002, 36(3):544-554.
10. Arai M, et al. Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem 2003, 278(32):29813-29818.
11. Aussilhou B, et al. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol 2009, 16(6):1553-1559.
12. Azoulay D, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000, 231(4):480-486.
13. Balasubramanian S, Paulose CS Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor. Hepatology 1998, 27(1):62-66.
14. Balzan S, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005, 242(6):824-828. discussion 828-829.
15. Banas A, et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008, 26(10):2705-2712.
16. Barrier A, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 2005, 19(12):1617-1626.
17. Behrns KE, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998, 2(3):292-298.
18. Belghiti J, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000, 191(1):38-46.
19. Berenguer M Live donor liver transplantation for hepatitis C: new data, old story. Liver Transpl 2006, 12(4):516-519.
20. Bilodeau M, et al. Evaluation of hepatocyte injury following partial ligation of the left portal vein. J Hepatol 1999, 30(1):29-37.
21. Bissig KD, et al. Epidermal growth factor is decreased in liver of rats with biliary cirrhosis but does not act as paracrine growth factor immediately after hepatectomy. J Hepatol 2000, 33(2):275-281.
22. Blindenbacher A, et al. Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 2003, 124(5):1465-1475.
23. Blumgart LH, Kelley CJ Hepaticojejunostomy in benign and malignant high bile duct stricture: approaches to the left hepatic ducts. Br J Surg 1984, 71(4):257-261.
24. Blumgart LH, Kelley CJ, Benjamin IS Benign bile duct stricture following cholecystectomy: critical factors in management. Br J Surg 1984, 71(11):836-843.
25. Bucher NLR, Swaffield MN The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res 1964, 24:1611-1625.
26. Burroughs AK, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006, 367(9506):225-232.
27. Campbell JS, et al. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 2001, 107(10):1285-1292.
28. Canbay A, et al. Fas enhances fibrogenesis in the bile duct-ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002, 123(4):1323-1330.
29. Cassuto JR, et al. The cumulative effects of cold ischemic time and older donor age on liver graft survival. J Surg Res 2008, 148(1):38-44.
30. Cataldegirmen G, et al. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J Exp Med 2005, 201(3):473-484.
31. Chang YJ, et al. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci 2009, 85(13-14):517-525.
32. Clavien PA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003, 238(6):843-850. discussion 851-842.
33. Clavien PA, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007, 356(15):1545-1559.
34. Clavien PA Liver regeneration: a spotlight on the novel role of platelets and serotonin. Swiss Med Wkly 2008, 138(25-26):361-370.
35. Corbin IR, et al. Regenerative activity and liver function following partial hepatectomy in the rat using (31)P-MR spectroscopy. Hepatology 2002, 36(2):345-353.
36. Cornell RP, Liljequist BL, Bartizal KF Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology 1990, 11(6):916-922.
37. Costa RH, et al. Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003, 38(6):1331-1347.
38. Covey AM, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 2008, 247(3):451-455.
39. Cressman DE, Diamond RH, Taub R Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology 1995, 21(5):1443-1449.
40. Cressman DE, et al. Liver failure and defective hepatocyte regeneration in interleukin-6- deficient mice. Science 1996, 274(5291):1379-1383.
41. Currier AR, et al. Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. Am J Physiol Gastrointest Liver Physiol 2003, 284(3):G508-G515.
42. Dabeva MD, Shafritz DA Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am J Pathol 1993, 143(6):1606-1620.
43. Dahm F, Georgiev P, Clavien P-A Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005, 5(11):2605-2610.
44. Das BC, Isaji S, Kawarada Y Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg 2001, 25(3):266-272.
45. Date M, et al. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J Hepatol 2000, 32(2):251-260.
46. Debonera F, et al. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J Surg Res 2001, 96(2):289-295.
47. Debonera F, et al. Partial liver grafts with prolonged cold preservation initiate blunted regenerative responses. Am J Transplant 2002, 2(Suppl 3):156.
48. Debonera F, et al. Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation. Hepatology 2003, 38(6):1563-1572.
49. Debonera F, et al. Severe preservation injury induces Il-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation. Am J Transplant 2004, 4(12):1964-1971.
50. de Jonge J, et al. Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 2009, 9(4):758-772.
51. Delany HM, et al. Contrasting effects of identical nutrients given parenterally or enterally after 70% hepatectomy. Am J Surg 1994, 167(1):135-143. discussion 143-134.
52. Demori I, et al. Increased insulin-like growth factor binding protein-4 expression after partial hepatectomy in the rat. Am J Physiol Gastrointest Liver Physiol 2000, 278(3):G384-G389.
53. Derynck R, Zhang YE Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425(6958):577-584.
54. De Silvestro G, et al. Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology 2004, 51(57):805-810.
55. Diamond RH, et al. Novel delayed-early and highly insulin-induced growth response genes: identification of HRS, a potential regulator of alternative pre-mRNA splicing. J Biol Chem 1993, 268(20):15185-15192.
56. di Bonzo LV, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008, 57(2):223-231.
57. Dinant S, et al. Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 2007, 48(5):685-692.
58. Dong J, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130(6):1120-1133.
59. Drixler TA, et al. Liver regeneration is an angiogenesis-associated phenomenon. Ann Surg 2002, 236(6):703-711. discussion 711-702.
60. Duncan AW, Dorrell C, Grompe M Stem cells and liver regeneration. Gastroenterology 2009, 137(2):466-481.
61. Eguchi S, et al. Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation. Liver Transpl 2003, 9(6):547-551.
62. Elmen J, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452(7189):896-899.
63. Emond JC, et al. Functional analysis of grafts from living donors: implications for the treatment of older recipients. Ann Surg 1996, 224(4):544-554.
64. Erhardt A, et al. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002, 292(2):272-284.
65. Esch JS, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005, 23(4):463-470.
66. Fang B, et al. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004, 78(1):83-88.
67. Farrell G Effects of disease on expression and regulation of CYPs. Mol Aspects Med 1999, 20(1-2):55-70. 137.
68. Fausto N Liver regeneration. J Hepatol 2000, 32(Suppl 1):19-31.
69. Fausto N Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004, 39(6):1477-1487.
70. Fausto N, Campbell JS The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003, 120(1):117-130.
71. Feingold KR, Soued M, Grunfeld C Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun 1988, 153(2):576-582.
72. Feng S, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006, 6(4):783-790.
73. Fernandez FG, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005, 200(6):845-853.
74. Fickert P, et al. Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol 2005, 42(3):378-385.
75. FitzGerald MJ, et al. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ 1995, 6(4):417-427.
76. Francavilla A, et al. Estradiol and testosterone levels in patients undergoing partial hepatectomy: a possible signal for hepatic regeneration?. Dig Dis Sci 1989, 34(6):818-822.
77. Francavilla A, et al. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology 1989, 9(4):614-620.
78. Francavilla A, et al. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology 1991, 14(1):140-143.
79. Francavilla A, et al. Effects of rapamycin on cultured hepatocyte proliferation and gene expression. Hepatology 1992, 15(5):871-877.
80. Francavilla A, et al. Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology 1994, 19(1):210-216.
81. Franchello A, et al. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). Am J Transplant 2009, 9(7):1629-1639.
82. Friedman RS, Krause DS Regeneration and repair: new findings in stem cell research and aging. Ann N Y Acad Sci 2009, 1172:88-94.
83. Fujita J, et al. Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery 2001, 129(1):48-54.
84. Fujiwara Y, et al. Cytokine characteristics of jaundice in mouse liver. Cytokine 2001, 13(3):188-191.
85. Fukuhara Y, et al. Gene expression profile in the regenerating rat liver after partial hepatectomy. J Hepatol 2003, 38(6):784-792.
86. Gehling UM, et al. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 2005, 43(5):845-853.
87. Ghahary A, et al. Effects of partial hepatectomy on hepatic insulinlike growth factor binding protein-1 expression. Hepatology 1992, 15(6):1125-1131.
88. Garcia-Retortillo M, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004, 40(3):699-707.
89. Ghobrial RM, et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation. Am J Transplant 2002, 2(Suppl 3):163.
90. Gomez L, et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2007, 293(3):H1654-H1661.
91. Gonzales E, et al. ATP release after partial hepatectomy regulates liver regeneration in the rat. J Hepatol 2010, 52(1):54-62.
92. Gressner AM Cytokines and cellular cross talk involved in the activation of fat-storing cells. J Hepatol 1995, 22(2 Suppl):28-36.
93. Grisham JW Cellular proliferation in the liver. Recent Results Cancer Res 1969, 17:28-43.
94. Gujral JS, et al. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 2004, 40(4):998-1007.
95. Haber BA, et al. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993, 91(4):1319-1326.
96. Haber BA, et al. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 1995, 95(2):832-841.
97. Hadjis NS, Blumgart LH Role of liver atrophy, hepatic resection and hepatocyte hyperplasia in the development of portal hypertension in biliary disease. Gut 1987, 28(8):1022-1028.
98. Hamanoue M, et al. Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology 1992, 16(6):1485-1492.
99. Harris RG, et al. Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 2004, 305(5680):90-93.
100. Hayashi J, et al. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology 2000, 32(5):958-961.
101. Heckel JL, et al. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 1990, 62(3):447-456.
102. Hemming AW, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003, 237(5):686-691. discussion 691-683.
103. Herrera MB, et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010, 14(6B):1605-1618.
104. Higashiyama H, et al. Graft size assessment by preoperative computed tomography in living related partial liver transplantation. Br J Surg 1993, 80(4):489-492.
105. Higashiyama R, et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007, 45(1):213-222.
106. Higgins GM, Anderson RM Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931, 12:186-202.
107. Holecek M Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review. Nutrition 1999, 15(10):784-788.
108. Hong JH, et al. dl-propranolol negatively regulates the transcription of proliferating cell nuclear antigen (PCNA)-gene and thereby suppresses DNA synthesis in regenerating rat liver. Biochem Mol Biol Int 1997, 42(1):103-112.
109. Houlihan DD, Newsome PN Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008, 135(2):438-450.
110. Hu RH, et al. Profile of hepatocyte growth factor in patients with obstructive jaundice. Hepatogastroenterology 2003, 50(54):1987-1990.
111. Huang W, et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006, 312(5771):233-236.
112. Huh CG, et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A 2004, 101(13):4477-4482.
113. Humar A, et al. Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl 2004, 10(3):374-378.
114. Hurwitz H, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350(23):2335-2342.
115. Iakova P, Awad SS, Timchenko NA Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 2003, 113(4):495-506.
116. Ibrahim S, et al. Liver regeneration and splenic enlargement in donors after living-donor liver transplantation. World J Surg 2005, 29(12):1658-1666.
117. Iida T, et al. Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation. Clin Transplant 2009, 23(2):271-277.
118. Ikeda K, et al. The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch Histol Cytol 1995, 58(2):171-184.
119. Ikegami T, et al. The impact of donor age on living donor liver transplantation. Transplantation 2000, 70(12):1703-1707.
120. Imamura H, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999, 29(4):1099-1105.
121. Ito A, Higashiguchi T Effects of glutamine administration on liver regeneration following hepatectomy. Nutrition 1999, 15(1):23-28.
122. Jaeschke H Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg 1998, 5(4):402-408.
123. Jalan R Acute liver failure: current management and future prospects. J Hepatol 2005, 42(Suppl 1):S115-S123.
124. Jang YY, et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004, 6(6):532-539.
125. Jarnagin WR, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002, 236(4):397-406. discussion 406-397.
126. Jassem W, et al. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation. Liver Transpl 2009, 15(12):1750-1765.
127. Jiang SM, et al. Role of splanchnic hemodynamics in liver regeneration after living donor liver transplantation. Liver Transpl 2009, 15(9):1043-1049.
128. Jin J, et al. The age-associated decline of glycogen synthase kinase 3 beta plays a critical role in the inhibition of liver regeneration. Mol Cell Biol 2009, 29(14):3867-3880.
129. Kallis YN, Alison MR, Forbes SJ Bone marrow stem cells and liver disease. Gut 2007, 56(5):716-724.
130. Kam I, Lynch S, Svanas G Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology 1987, 7(2):362-366.
131. Kamel IR, et al. Liver regeneration after living adult right lobe transplantation. Abdom Imaging 2003, 28(1):53-57.
132. Kan NG, Junghans D, Izpisua Belmonte JC Compensatory growth mechanisms regulated by BMP and FGF signaling mediate liver regeneration in zebrafish after partial hepatectomy. FASEB J 2009, 23(10):3516-3525.
133. Kaplowitz N Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002, 22(2):137-144.
134. Karoui M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006, 243(1):1-7.
135. Khatri VP, Petrelli NJ, Belghiti J Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol 2005, 23(33):8490-8499.
136. Khurana S, Mukhopadhyay A Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue. Stem Cells 2007, 25(6):1439-1447.
137. Kim RD, Stein GS, Chari RS Impact of cell swelling on proliferative signal transduction in the liver. J Cell Biochem 2001, 83(1):56-69.
138. Kim TH, et al. Differential expression and distribution of focal adhesion and cell adhesion molecules in rat hepatocyte differentiation. Exp Cell Res 1998, 244(1):93-104.
139. Kim TH, et al. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology 2000, 31(1):75-82.
140. Kiuchi T, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999, 67(2):321-327.
141. Kofman AV, et al. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 2005, 41(6):1252-1261.
142. Koga M, Ogasawara H Induction of hepatocyte mitosis in intact adult rat by interleukin-1 alpha and interleukin-6. Life Sci 1991, 49(17):1263-1270.
143. Kohli V, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999, 67(8):1099-1105.
144. Koli K, et al. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008, 10(2):333-342.
145. Koniaris LG, et al. Liver regeneration. J Am Coll Surg 2003, 197(4):634-659.
146. Kooby DA, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003, 7(8):1034-1044.
147. Kountouras J, Billing BH, Scheuer PJ Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984, 65(3):305-311.
148. Krupczak-Hollis K, et al. Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b. Hepatology 2003, 38(6):1552-1562.
149. Kubota K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision making in resectional surgery for hepatic tumors. Hepatology 1997, 26(5):1176-1181.
150. Kuo TK, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008, 134(7):2111-2121.
151. Kurumiya Y, et al. Differential suppression of liver-specific genes in regenerating rat liver induced by extended hepatectomy. J Hepatol 2000, 32(4):636-644.
152. Lagasse E, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6(11):1229-1234.
153. Lau H, et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997, 84(9):1255-1259.
154. LeCouter J, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003, 299(5608):890-893.
155. Lee MN, et al. Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway. J Gen Virol 2002, 83(Pt 9):2145-2151.
156. Lenaz G, et al. Mitochondrial bioenergetics in aging. Biochim Biophys Acta 2000, 1459(2-3):397-404.
157. Lesurtel M, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006, 312(5770):104-107.
158. Leu JI, et al. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 2001, 21(2):414-424.
159. Leu JI, et al. Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 2003, 23(4):1251-1259.
160. Li W, et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002, 277(32):28411-28417.
161. Lin WR, Brittan M, Alison MR The role of bone marrow-derived cells in fibrosis. Cells Tissues Organs 2008, 188(1-2):178-188.
162. Lo CM, et al. Minimum graft size for successful living donor liver transplantation. Transplantation. 1999, 68(8):1112-1116.
163. Lonn P, et al. Regulating the stability of TGFbeta receptors and Smads. Cell Res 2009, 19(1):21-35.
164. Lory J, et al. The pathology of the atrophy/hypertrophy complex (AHC) of the liver: a light microscopic and immunohistochemical study. Histol Histopathol 1994, 9(3):541-554.
165. Macías-Silva M, et al. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-? signals during liver regeneration. J Biol Chem 2002, 277(32):28483-28490.
166. Maes OC, et al. Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 2008, 129(9):534-541.
167. Makuuchi M, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987, 164(2):155-158.
168. Man K, et al. Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts. Liver Transpl 2003, 9(4):425-432.
169. Mann DV, et al. Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology 2001, 34(3):557-565.
170. Mann DV, et al. Metabolic control patterns in acute phase and regenerating human liver determined in vivo by 31-phosphorus magnetic resonance spectroscopy. Ann Surg 2002, 235(3):408-416.
171. Marcos A, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000, 69(7):1375-1379.
172. Marcos A, et al. Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation 2000, 69(11):2410-2415.
173. Marshall A, et al. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 2005, 128(1):33-42.
174. Matsumoto T, et al. Insulin gene transfer with adenovirus vector via the spleen safely and effectively improves posthepatectomized conditions in diabetic rats. J Surg Res 2003, 110(1):228-234.
175. McCormack L, et al. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 2007, 245(6):923-930.
176. Michalopoulos G, et al. Control of hepatocyte replication by two serum factors. Cancer Res 1984, 44(10):4414-4419.
177. Michalopoulos GK, DeFrances MC Liver regeneration. Science 1997, 276(5309):60-66.
178. Mischoulon D, et al. Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBP alpha) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol Cell Biol 1992, 12(6):2553-2560.
179. Mitchell C, et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 2005, 280(4):2562-2568.
180. Miyoshi H, et al. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999, 117(3):669-677.
181. Mohn KL, et al. Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells: liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families. J Biol Chem 1990, 265(35):21914-21921.
182. Monga SP Role of Wnt/beta-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol 2009, 43(7):1021-1029.
183. Monga SP, et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 2002, 62(7):2064-2071.
184. Moolten FL, Bucher NL Regeneration of rat liver: transfer of humoral agent by cross circulation. Science 1967, 158(798):272-274.
185. Morello D, et al. c-myc, c-fos, and c-jun regulation in the regenerating livers of normal and H-2K/c-myc transgenic mice. Mol Cell Biol 1990, 10(6):3185-3193.
186. Morita T, et al. Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg 2002, 9(3):352-359.
187. Nadalin S, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl 2004, 10(8):1024-1029.
188. Nagasue N, et al. Human liver regeneration after major hepatic resection: a study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987, 206(1):30-39.
189. Nagy P, et al. Dexamethasone inhibits the proliferation of hepatocytes and oval cells but not bile duct cells in rat liver. Hepatology 1998, 28(2):423-429.
190. Nakano K, Chijiiwa K, Tanaka M Lower activity of CCAAT/enhancer-binding protein and expression of cyclin E, but not cyclin D1, activating protein-1 and p21 (WAF1), after partial hepatectomy in obstructive jaundice. Biochem Biophys Res Commun 2001, 280(3):640-645.
191. Nakao A, et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997, 16(17):5353-5362.
192. Neuschwander-Tetri BA, Caldwell SH Nonalcoholic steatohepatitis: summary of an AASLD single-topic conference. Hepatology 2003, 37(5):1202-1219.
193. Nishimura Y, Romer LH, Lemasters JJ Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured rat hepatic sinusoidal endothelial cells: the pH paradox and cytoprotection by glucose, acidotic pH, and glycine. Hepatology 1998, 27(4):1039-1049.
194. Nishizaki T, et al. Nutritional support after hepatic resection: a randomized prospective study. Hepatogastroenterology 1996, 43(9):608-613.
195. Nocito A, et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007, 45(2):369-376.
196. Oertel M, Shafritz DA Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008, 1782(2):61-74.
197. Olthoff KM Molecular pathways of regeneration and repair after liver transplantation. World J Surg 2002, 26(7):831-837.
198. Olthoff KM Hepatic regeneration in living donor liver transplantation. Liver Transplant 2003, 9(10C):S35-S41.
199. Oyagi S, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 2006, 44(4):742-748.
200. Palmes D, et al. Impact of rapamycin on liver regeneration. Virchows Arch 2008, 452(5):545-557.
201. Pamecha V, et al. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer 2009, 100(4):617-622.
202. Parekkadan B, et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007, 2(9):e941.
203. Petersen BE, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284(5417):1168-1170.
204. Pomfret EA, et al. Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 2003, 76(1):5-10.
205. Pottakkat B, et al. Surgical management of patients with post-cholecystectomy benign biliary stricture complicated by atrophy-hypertrophy complex of the liver. HPB (Oxford) 2009, 11(2):125-129.
206. Poynard T, Opolon P, Bedossa P Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997, 349(9055):825-832.
207. Rabes HM, et al. Analysis of cell cycle compartments of hepatocytes after partial hepatecomy. Cell Tissue Kinet 1976, 9(6):517-532.
208. Rai RM, et al. Impaired liver regeneration in inducible nitric oxide synthase deficient mice. Proc Natl Acad Sci U S A 1998, 95(23):13829-13834.
209. Ray RB, et al. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 1998, 208(2):331-336.
210. Reddy BV, Irvine KD The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation. Development 2008, 135(17):2827-2838.
211. Reddy SK, et al. Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg 2008, 206(1):96-106.
212. Repa JJ, et al. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia: reversal by cholic acid feeding. J Biol Chem 2000, 275(50):39685-39692.
213. Reynolds ES Liver parenchymal cell injury. I. Initial alterations of the cell following poisoning with carbon tetrachloride. J Cell Biol 1963, 19:139-157.
214. Rhim JA, et al. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994, 263(5150):1149-1152.
215. Ribero D, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007, 94(11):1386-1394.
216. Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
217. Roderfeld M, et al. Bone marrow transplantation demonstrates medullar origin of CD34(+) fibrocytes and ameliorates hepatic fibrosis in Abcb4(?/?) mice. Hepatology 2010, 51(1):267-276.
218. Rolando N, et al. Prospective controlled trial of selective parenteral and enteral antimicrobial regimens in fulminant liver failure. Hepatology 1993, 17(2):196-201.
219. Ronco MT, et al. Modulation of balance between apoptosis and proliferation by lipid peroxidation (LPO) during rat liver regeneration. Mol Med 2002, 8(12):808-817.
220. Rosa JL, Bartrons R, Tauler A Gene expression of regulatory enzymes of glycolysis/gluconeogenesis in regenerating rat liver. Biochem J 1992, 287(Pt 1):113-116.
221. Roskams T, et al. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol 1998, 29(3):455-463.
222. Rubbia-Brandt L, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004, 15(3):460-466.
223. Rudiger HA, et al. Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg 2002, 235(3):400-407.
224. Rudnick DA, Perlmutter DH, Muglia LJ Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A 2001, 98(15):8885-8890.
225. Russo FP, et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006, 130(6):1807-1821.
226. Saiki S, et al. Preoperative internal biliary drainage is superior to external biliary drainage in liver regeneration and function after hepatectomy in obstructive jaundiced rats. Ann Surg 1999, 230(5):655-662.
227. Sakaida I, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004, 40(6):1304-1311.
228. Sass DA, Shakil AO Fulminant hepatic failure. Liver Transpl 2005, 11(6):594-605.
229. Scappaticci FA, et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 2005, 91(3):173-180.
230. Scatton O, et al. Impact of localized congestion related to venous deprivation after hepatectomy. Surgery 2008, 143(4):483-489.
231. Seehofer D, et al. Intraabdominal bacterial infections significantly alter regeneration and function of the liver in a rat model of major hepatectomy. Langenbecks Arch Surg 2007, 392(3):273-284.
232. Sekine K, Fujishima S, Aikawa N Plasma hepatocyte growth factor is increased in early-phase sepsis. J Infect Chemother 2004, 10(2):110-114.
233. Selzner M, et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000, 32(6):1280-1288.
234. Selzner M, Camargo CA, Clavien P-A Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 1999, 30(2):469-475.
235. Selzner N, et al. Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-?/IL-6-dependent mechanism. Hepatology 2002, 36(4 Pt 1):812-818.
236. Shibayama Y, Hashimoto K, Nakata K Recovery from hepatic necrosis following acute portal vein embolism with special reference to reconstruction of occluded vessels. J Pathol 1991, 165(3):255-261.
237. Shiffman ML, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004, 10(10):1248-1255.
238. Shoup M, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003, 7(3):325-330.
239. Shrivastava A, et al. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol 1998, 72(12):9722-9728.
240. Shteyer E, et al. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 2004, 40(6):1322-1332.
241. Skullman S, Ihse I, Larsson J Influence of malnutrition on regeneration and composition of the liver in rats. Acta Chir Scand 1990, 156(10):717-722.
242. Starzl TE, et al. A hundred years of the hepatotrophic controversy. Ciba Found Symp 1977, 55:111-129.
243. Starzl TE, Porter KA, Kashiwagi N Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet 1975, 141(6):843-858.
244. Steller H Mechanisms and genes of cellular suicide. Science 1995, 267(5203):1445-1449.
245. Stocker E, Heine WD Regeneration of liver parenchyma under normal and pathological conditions. Beitr Pathol 1971, 144(4):400-408.
246. Streetz KL, et al. Interleukin 6 and liver regeneration. Gut 2000, 47(2):309-312.
247. Strey CW, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003, 198(6):913-923.
248. Strey CW, et al. Partial hepatectomy-induced liver proteome changes in mice. Proteomics 2004, 4:1-8.
249. Su AI, et al. Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci U S A 2002, 99(17):11181-11186.
250. Suc B, et al. "Natural history" of hepatectomy. Br J Surg 1992, 79(1):39-42.
251. Sun R, Gao B Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 2004, 127(5):1525-1539.
252. Suzuki H, et al. Internal biliary drainage, unlike external drainage, does not suppress the regeneration of cholestatic rat liver after partial hepatectomy. Hepatology 1994, 20(5):1318-1322.
253. Taguchi T, Fukuda M, Ohashi M Differences in DNA synthesis in vitro using isolated nuclei from regenerating livers of young and aged rats. Mech Ageing Dev 2001, 122(2):141-155.
254. Takamura K, et al. Possible endocrine control by follistatin 315 during liver regeneration based on changes in the activin receptor after a partial hepatectomy in rats. Hepatogastroenterology 2005, 52(61):60-66.
255. Takamura K, et al. Activin and activin receptor expression changes in liver regeneration in rat. J Surg Res 2005, 126(1):3-11.
256. Tamasi V, et al. The effect of dexamethasone on P450 activities in regenerating rat liver. Biochem Biophys Res Commun 2001, 286(2):239-242.
257. Tanaka K, Yamada T Living donor liver transplantation in Japan and Kyoto University: what can we learn?. J Hepatol 2005, 42(1):25-28.
258. Taub R Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest 2003, 112(7):978-980.
259. Taub R Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004, 5(10):836-847.
260. Theise ND, et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999, 30(6):1425-1433.
261. Theise ND, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000, 31(1):235-240.
262. Theise ND, et al. Liver from bone marrow in humans. Hepatology 2000, 32(1):11-16.
263. Theise ND, Krause DS Bone marrow to liver: the blood of Prometheus. Semin Cell Dev Biol 2002, 13(6):411-417.
264. Thevananther S, et al. Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 2004, 39(2):393-402.
265. Thompson NL, et al. Sequential protooncogene expression during rat liver regeneration. Cancer Res 1986, 46(6):3111-3117.
266. Timchenko NA Aging and liver regeneration. Trends Endocrinol Metab 2009, 20(4):171-176.
267. Togo S, et al. Mechanism of liver regeneration after partial hepatectomy using mouse cDNA microarray. J Hepatol 2004, 40(3):464-471.
268. Tracy TF, et al. Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration. Surgery 1991, 110(2):176-182. discussion 182-173.
269. Tralhao JG, et al. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A 2002, 99(10):6991-6996.
270. Trotter JF, et al. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. Liver. Transpl 2002, 8(3):212-218.
271. Tucker ON, Heaton N The "small for size" liver syndrome. Curr Opin Crit Care 2005, 11(2):150-155.
272. Uemura T, et al. Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats. Int J Mol Med 2000, 5(2):173-179.
273. Van Buren G, et al. Effect of molecular therapeutics on liver regeneration in a murine model. J Clin Oncol 2008, 26(11):1836-1842.
274. van Poll D, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008, 47(5):1634-1643.
275. Vassilopoulos G, Wang PR, Russell DW Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422(6934):901-904.
276. Vauthey JN, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000, 127(5):512-519.
277. Vauthey JN, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006, 24(13):2065-2072.
278. Vauthey JN, Zorzi D In search of the black sheep: is it bevacizumab or extended chemotherapy?. Ann Surg Oncol 2009, 16(6):1463-1464.
279. Verran D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003, 9(5):500-505.
280. Vogten JM, et al. Angiostatin inhibits experimental liver fibrosis in mice. Int J Colorectal Dis 2004, 19(4):387-394.
281. Wang X, et al. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 2003, 101(10):4201-4208.
282. Wang X, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422(6934):897-901.
283. Webber EM, Fausto N, Godowski PJ In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994, 19(2):489-497.
284. Weiss YG, et al. Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats. Am J Physiol Gastrointest Liver Physiol 2001, 280(5):G968-G973.
285. Weymann A, et al. p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology 2009, 50(1):207-215.
286. Widmann JJ, Fahimi HD Proliferation of mononuclear phagocytes (Kupffer cells) and endothelial cells in regenerating rat liver: a light and electron microscopic cytochemical study. Am J Pathol 1975, 80(3):349-366.
287. Wu CC, et al. Prospective randomized trial of systemic antibiotics in patients undergoing liver resection. Br J Surg 1998, 85(4):489-493.
288. Wuestefeld T, et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003, 278(13):11281-11288.
289. Yamada T, et al. Insulin requirements for hepatic regeneration following hepatectomy. Ann Surg 1977, 185(1):35-42.
290. Yamada Y, et al. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997, 94(4):1441-1446.
291. Yamanaka N, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993, 18(1):79-85.
292. Yan Y, et al. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int 2009, 29(3):356-365.
293. Yang SQ, et al. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 2001, 34(4 Pt 1):694-706.
294. Yigitler C, et al. The small remnant liver after major liver resection: how common and how relevant?. Liver Transpl 2003, 9(9):S18-S25.
295. Yokoi H, et al. Donor outcome and liver regeneration after right-lobe graft donation. Transpl Int 2005, 18(8):915-922.
296. Yokoyama Y, Nagino M, Nimura Y Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 2007, 31(2):367-374.
297. Yokoyama Y, Nagino M, Nimura Y Which gender is better positioned in the process of liver surgery? Male or female?. Surg Today 2007, 37(10):823-830.
298. Zhao DC, et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 2005, 11(22):3431-3440.
299. Zhao Q, et al. Stem/progenitor cells in liver injury repair and regeneration. Biol Cell 2009, 101(10):557-571.
300. Zhong Z, et al. Liver regeneration is suppressed in small-for-size liver grafts after transplantation: involvement of c-Jun N-terminal kinase, cyclin D1, and defective energy supply. Transplantation 2006, 82(2):241-250.
301. Zhong Z, et al. Inhibition of TGF-?/Smad signaling improves regeneration of small-for-size rat liver grafts. Liver Transpl 2010, 16(2):181-190.
302. Zimmers TA, et al. Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology 2003, 38(2):326-334.